NCT03163446 - Safety, Efficacy and Pharmacokinetics of CF-301 vs. Placebo in Addition to Antibacterial Therapy for Treatment of S. Aureus Bacteremia | Biotech Hunter

Enrollment

121

Participants

Timeline

Start Date

May 23, 2017

Primary Completion Date

March 7, 2019

Study Completion Date

March 7, 2019

Conditions

Staphylococcus Aureus BacteremiaStaphylococcus Aureus Endocarditis

Interventions

BIOLOGICAL

CF-301

CF-301, 0.25 mg/kg, given as a single 2 hour iv infusion

DRUG

Placebo

Placebo, given as a single 2 hour iv infusion

Trial Locations (78)

10029

CF-301-102 Study Site, New York

10065

CF-301-102 Study Site, New York

10595

CF-301-102 Study Site, Valhalla

18015

CF-301-102 Study Site, Bethlehem

19713

CF-301-102 Study Site, Newark

23298

Cf-301-102, Richmond

24014

CF-301-102 Study Site, Roanoke

30033

CF0301-102 Study Site, Decatur

30322

CF-301-102 Study Site, Atlanta

30912

CF-301-102 Study Site, Augusta

35233

CF-301-102 Study Site, Birmingham

43210

CF301-102 Study Site, Columbus

43215

Cf-301-102, Columbus

43608

CF-301 Study Site, Toledo

44106

CF-301-102 Study Site, Cleveland

48073

CF301-102 Study Site, Royal Oak

48201

CF-301-102 Study Site, Detroit

53226

CF-301-102 Study Site, Milwaukee

59701

CF301-102 Study site, Butte

60637

CF301-102 Study Site, Chicago

63110

CF301-102 Study Site, St Louis

68131

CF301-102 Study Site, Omaha

68198

CF-301-102 Study Site, Omaha

83404

CF-301 Study Site, Idaho Falls

91342

CF301-102 Study Site, Sylmar

95817

CF-301-102 Study Site, Sacramento

98195

CF-301-102 Study Site, Seattle

06511

CF-301-102 Study Site, New Haven

01805

CF301-102 Study Site, Burlington

07631

CF-301-102 Study Site, Englewood

07102

CF301-102 Study Site, Paterson

Unknown

CF-301-102 Study Site #2, Brussels

CF301-102 Study Site, Brussels

CF301-102 Study Site, Edegem

CF301-102 Study Site, Ghent

CF301-102 Study Site, Leuven

CF301-102 Study Site, Rousse

CF301-102 Study Site, Sofia

CF-301-102 Study Site, Santiago

CF-301-102 Study Site, Viña del Mar

CF301-102 Study Site, Brno

CF301-102 Study Site #2, Prague

CF301-102 Study Site, Prague

CF301-102 Study Site, Limoges

CF301-102 Study Site, Lyon

CF301-102 Study Site, Paris

CF301-102 Study Site, Toulon

CF-301-102 Study Site #2, Berlin

CF-301-102 Study Site, Berlin

CF-301-102 Study Site, Cologne

CF-301-102 Study Site, Freiburg im Breisgau

CF301-102 Study Site #3, Athens

CF301-102 Study Site, Athens

Study Site #2, Athens

CF301-102 Study Site, Larissa

CF-301-102 Study Site, Guatemala City

CF-301-102 Study Site, Santa Rosita

CF301-102 Study Site, Beersheba

CF301-102 Study Site, Nazareth

CF301-102 Study Site, Safed

CF301-102 Study Site, Tel Litwinsky

CF301-102 Study Site, Bergamo

CF-301-102 Study Site, Busto Arsizio

CF-301-102 Study Site, Genoa

CF-301-102 Study Site, Krasnodar

CF-301-102 Study Site, Moscow

CF-301-102 Study Site, Saint Pertersburg

CF-301-102 Study Site #2, Saint Petersburg

CF-301-102 Study Site #2, Barcelona

Cf301-102, Barcelona

CF301-102 Study Site, Córdoba

CF301-102 Study Site, Seville

CF301-102 Study Site, Terrassa

CF301-102 Study Site, Chelmsford

CF301-102 Study Site, Liverpool

CF-301-102 Study Site, London

CF301-102 Study Site #2, London

CF301-102 Study Site, Oxford